Waldenstrom Macroglobulinemia
"Waldenstrom Macroglobulinemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum IMMUNOGLOBULIN M. There is lymphoplasmacytic cells infiltration into bone marrow and often other tissues, also known as lymphoplasmacytic lymphoma. Clinical features include ANEMIA; HEMORRHAGES; and hyperviscosity.
| Descriptor ID |
D008258
|
| MeSH Number(s) |
C04.557.595.925 C14.907.454.960 C15.378.147.780.925 C15.378.463.515.960 C15.604.515.925 C20.683.780.925
|
| Concept/Terms |
Waldenstrom Macroglobulinemia- Waldenstrom Macroglobulinemia
- Macroglobulinemia, Waldenstrom
- Lymphoma, Lymphoplasmacytoid
- Lymphomas, Lymphoplasmacytoid
- Lymphoplasmacytoid Lymphoma
- Lymphoplasmacytoid Lymphomas
- Macroglobulinemia
- Waldenstrom's Macroglobulinemia
- Macroglobulinemia, Waldenstrom's
- Waldenstroms Macroglobulinemia
- Waldenstrom's Macroglobulinaemia
- Macroglobulinaemia, Waldenstrom's
- Waldenstrom Macroglobulinaemia
- Waldenstroms Macroglobulinaemia
- Lymphoma, Lymphocytic, Plasmacytoid
- Primary Macroglobulinemia
- Macroglobulinemia, Primary
Familial Waldenstrom's Macroglobulinaemia- Familial Waldenstrom's Macroglobulinaemia
- Familial Waldenstrom Macroglobulinaemia
- Familial Waldenstroms Macroglobulinaemia
- Macroglobulinaemia, Familial Waldenstrom's
- Waldenstrom's Macroglobulinaemia, Familial
|
Below are MeSH descriptors whose meaning is more general than "Waldenstrom Macroglobulinemia".
Below are MeSH descriptors whose meaning is more specific than "Waldenstrom Macroglobulinemia".
This graph shows the total number of publications written about "Waldenstrom Macroglobulinemia" by people in this website by year, and whether "Waldenstrom Macroglobulinemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Waldenstrom Macroglobulinemia" by people in Profiles.
-
Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenstr?m macroglobulinemia. Neoplasia. 2021 04; 23(4):361-374.
-
Utility of quantitative flow cytometry immunophenotypic analysis of CD5 expression in small B-cell neoplasms. Arch Pathol Lab Med. 2014 Jul; 138(7):903-9.
-
Waldenstr?m macroglobulinemia: a review of the entity and its differential diagnosis. Adv Anat Pathol. 2012 Jan; 19(1):11-27.
-
Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study. Cancer. 2012 Aug 01; 118(15):3793-800.
-
Residual monotypic plasma cells in patients with waldenstrom macroglobulinemia after therapy. Am J Clin Pathol. 2011 Mar; 135(3):365-73.
-
Multiple myeloma and immunosecretory disorders: an update. Adv Anat Pathol. 2008 Jul; 15(4):196-210.
-
Cranial and peripheral neuropathy due to leptomeningeal infiltration in a patient with Waldenstrom's macroglobulinemia. J Neurol. 2007 Aug; 254(8):1122-3.
-
Recognizing hyperviscosity syndrome in patients with Waldenstrom macroglobulinemia. Clin J Oncol Nurs. 2007 Feb; 11(1):87-95.
-
Use of bortezomib in B-cell non-Hodgkin's lymphoma. Expert Rev Anticancer Ther. 2006 Jul; 6(7):983-91.
-
Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenstr?m macroglobulinemia and does not correlate with p65 NF-kappaB activation. Mod Pathol. 2006 Jul; 19(7):891-8.